IV NEWS
Events and training - November 20, 2023
Danish vascular access team facilitates shift to home care
When possible, certain patients may be better treated in the comfort of their home. Before 2014, Dr Bo Gottschau noticed…
News and innovation November 6, 2023
Straight to the point: how to better manage needle phobia
Are you having trouble administering injections to patients with needle phobia? The fear of needles is frequent. An estimated 63%…
“Complications of IV catheter therapy are simply the result of one complex and highly variable mechanical system—IV catheter equipment design,...
Scientific publications October 30, 2023
What can we learn from the new regional anaesthesia survey?
Over the last 20 years, regional anaesthesia practices have evolved with increased use, largely thanks to ultrasound, technical improvements and…
Scientific publications October 23, 2023
PICC lines: comparing infections in cancer vs noncancer patients
PICC lines are frequently used in cancer care Due to their ease of placement, peripherally inserted central line catheters or…
Events and training October 16, 2023
3 ways digital tools can help address vascular access complications
“Health organisations must promote a global vascular access strategy with specific actions for reporting, preventing, identifying and quantifying complications,” said…
Scientific publications October 9, 2023
New clinical safety tips for syringe pump systems for microinfusion
Though advances in technology have brought improvements in education, there is still a general lack of awareness among healthcare workers…
News and innovation October 2, 2023
The push to build vascular access teams in Ireland
Almost 50% of all reported cases of Staphylococcus aureus bloodstream infection (BSI) in the Irish hospital system are associated with…
Fast fact
TIVA anaesthesia
Propofol-based total intravenous anaesthesia (TIVA) emits four orders of magnitude less greenhouse gases than inhaled anaesthesia with desflurane and N2O.